Nicholas Shekerdemian

Inflection Point Acquisition Corp is a special purpose acquisition company with the intention of pursuing North American and European businesses in the consumer and technology sectors, which complements the expertise of our management team.

Building the record label of the 21st century. Based in Stockholm and LA. General Inquiries: contact@snafurecords.com Sync & Licensing Requests: licensing@snafurecords.com

Now part of MyHealthChecked PLC (acquired July 2021) Nell Health was a one-stop platform that generates actionable advice based on genetic data tailored to every, amazing body.

Radix is the only decentralized network where developers will be able to build quickly without the constant threat of exploits and hacks, where every improvement will get rewarded, and where scale will never be a bottleneck. Official Links: 1. Website -> https://radixdlt.com 2. Blog -> https://radixdlt.com/blog 3. FAQ -> https://radixdlt.com/faq 4. Telegram -> https://t.me/radix_dlt 5. Twitter -> https://twitter.com/radixdlt 6. Discord -> https://discord.gg/7Q7HSZZ 7. Reddit -> https://www.reddit.com/r/Radix/ 9. Facebook -> https://www.facebook.com/RadixDLT/

We're on a mission to help businesses become happier and healthier from the InsideOut. InsideOut is a multiple award-winning health tech platform using generative AI to provide on-demand, highly personalised and immersive preventive support. Underpinned by clinical research and evidence, InsideOut provides employees with on-demand virtual talking therapies, AI guided conversations (via Remi, our AI Coach), and a range of personalised exercises, tools and resources. Furthermore, we offer VR-based immersive programmes, which are clinically designed to mitigate feelings of stress, anxiety and burnout. At our core, we believe that employees perform at their greatest when they feel their best. We enable employees to access support to help with challenges they may be facing or achieve their goals whether that is sleeping better, managing stress, overcoming financial challenges, being more active or eating more healthily. Studies show that physical and mental health are interlinked, and that both are critical in order to bring our best selves to work. Now is the time to encourage colleagues to speak up about their wellbeing and to support them in letting the inside out.

Axis is the digital meetings and workshops facilitation tool for great consultants and professionals. Using anonymous ideas-sharing and evaluation activities, we bring impact, engagement and value to every session.

FidoCure is the first and only service to offer cancer care with a dual-focus approach that benefits both dogs and humans. Leveraging the genetic similarities between human and canine cancers, FidoCure offers targeted therapies that allow for more effective treatments extending dog lives by up to 3x. Through our Next Generation DNA Sequencing Test, the first of its kind to introduce human-grade targeted treatments to our canine companions, we have assembled the worlds largest canine cancer genomics database which uses genomic testing to provide veterinarians with critical data, enabling them to tailor the most effective targeted therapies for each individual dog patient. You can view our peer reviewed research in Nature Precision Oncology Journal and Nature Scientific Reports. FidoCure is proud to be leading precision medical research in canine oncology, and our team is committed to revolutionizing the way cancer care is delivered to dogs and humans alike. Our technology provides advanced diagnostics and facilitates access to precision medicines at the touch of a button. FidoCure by the One Health Company is backed by premier biotech investors including Polaris Ventures, A16Z, and YCombinator. Our vision along with our stakeholders, is a world free of cancer achieved by cost-effective, personalized precision medicine for both humans and their canine companions. Learn more at www.fidocure.com.

SPARK Neuro is a leading applied neuroscience company that collects and quantifies data to create machine-learning based brain health biomarkers for better clinical care and therapeutic discovery. SPARK’s Drug Development Dashboard provides intelligence on drug behavior at the earliest stages, saving time and money throughout the course of drug development.

We cultivate authentic materials without compromise,by harnessing science and nature responsibly by partnering the most innovative minds in science and technology with the finest craftspeople to accelerate the use of cellular agriculture for good. Our first product is slaughter-free, real leather.

HelixNano is building the worlds most advanced mRNA platform to enable previously impossible applications across human and non-human biology

Startup Network in London

Inflection Point Acquisition Corp is a special purpose acquisition company with the intention of pursuing North American and European businesses in the consumer and technology sectors, which complements the expertise of our management team.

Forbes Media is a global media, branding and technology company, with a focus on news and information about business, investing, technology, entrepreneurship, leadership and affluent lifestyles. The company publishes Forbes, Forbes Asia, and Forbes Europe magazines as well as Forbes.com. The Forbes brand today reaches more than 94 million people worldwide with its business message each month through its magazines and 37 licensed local editions around the globe, Forbes.com, TV, conferences, research, social and mobile platforms. Forbes Media’s brand extensions include conferences, real estate, education, financial services, and technology license agreements. Forbes is an equal opportunity employer.

Building the record label of the 21st century. Based in Stockholm and LA. General Inquiries: contact@snafurecords.com Sync & Licensing Requests: licensing@snafurecords.com

TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders. Led by a seasoned team of venture investors, ex-founders, and investment management executives, we invest our capital, time, and network into highly defensible, fast-growing companies with the potential to solve the world’s largest problems. Our strategy is grounded on writing high conviction checks at Pre-Seed and Seed with healthy follow-on reserves through Series A; demonstrating deep value to enable increased ownership over time. Our experienced team is headquartered in New York City and London, but we are excited to meet founders from around the world with a strong preference for diverse founding teams. At its core, we believe that diversity is not only good for business, but great for financial returns.